SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-088761
Filing Date
2022-03-30
Accepted
2022-03-30 08:26:40
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d280487ds3.htm S-3 478342
2 EX-4.3 d280487dex43.htm EX-4.3 514078
3 EX-4.5 d280487dex45.htm EX-4.5 561414
4 EX-5.1 d280487dex51.htm EX-5.1 63052
5 EX-5.2 d280487dex52.htm EX-5.2 12351
6 EX-23.3 d280487dex233.htm EX-23.3 1636
7 EX-FILING FEES d280487dexfilingfees.htm EX-FILING FEES 67082
8 GRAPHIC g280487g0329102329863.jpg GRAPHIC 2648
9 GRAPHIC g280487g20s85.jpg GRAPHIC 38220
  Complete submission text file 0001193125-22-088761.txt   1751175
Mailing Address 108 CANNON STREET LONDON X0 EC4N 6EU
Business Address 108 CANNON STREET LONDON X0 EC4N 6EU 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-263967 | Film No.: 22783316
SIC: 2836 Biological Products, (No Diagnostic Substances)